Details for 2019830950
Up to date per 02.04.2026
Actions
Details for 2019830950
Granted/Registered
European Patent
12.05.2021 A
18.06.2025 B1
03.07.2018
US
201862693503 P
03.07.2018
US
201862693502 P
A61K 9/00 20060101AFI20240521BHEP
Owner
Fennec Pharmaceuticals, Inc.68 TW Alexander Drive Research Triangle Park NC 27709US
Representative
Authorized Recipients
Dipl.-Phys. Bernhard Ganahlc/o HGF Europe LLP, Rudolfskai 485020 SalzburgAT
Inventor
SMITH, Alexander Apex NC27502US
Information about Fees